JNJ
2026Q2BMOJohnson & Johnson primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS2.84
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.4%
IV front—
P/C full—
P/C front—
Features as of2026-07-14
Run-up
Close—
Ret 5d-5.0%
Ret 10d-1.8%
Ret 20d+5.4%
Ret 30d+12.7%
Actual EPS
2.90Beat
Estimated EPS2.84
Actual revenue
25.3B
Surprise %+2.1%
Beat / missBeat
Beat streak 42
Beat streak 82
Reaction
1-day stock reaction-1.2%
Implied vs actual
Implied 2.4%Actual 1.5%
Gap reaction-1.5%
Day result-2.7%
Next-day upNo
Realized / IV0.62×
Post tape
Post 5d+3.5%
Post 10d+7.5%
Post volume10.5M
Vol ×10d1.45×
Vol ×20d1.18×
Post range4.3%